MELBOURNE, Australia and SAN FRANCISCO, June 23, 2025 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (Alterity or the Company), a biotechnology company dedicated to developing dis… [+4694 chars]...